| Identification | Back Directory | [Name]
5-methyl-3-phenyl-N-[4-(pyrimidin-2-ylsulfamoyl)phenyl]-1,2-oxazole-4-carboxamide | [CAS]
547704-53-0 | [Synonyms]
WAY-321873
5-methyl-3-phenyl-N-[4-(pyrimidin-2-ylsulfamoyl)phenyl]-1,2-oxazole-4-carboxamide
5-Methyl-3-phenyl-N-(4-(N-(pyrimidin-2-yl)sulfamoyl)phenyl)isoxazole-4-carboxamide
4-Isoxazolecarboxamide, 5-methyl-3-phenyl-N-[4-[(2-pyrimidinylamino)sulfonyl]phenyl]- | [Molecular Formula]
C21H17N5O4S | [MDL Number]
MFCD03397735 | [MOL File]
547704-53-0.mol | [Molecular Weight]
435.46 |
| Hazard Information | Back Directory | [Uses]
AKT-IN-26 (Compound 453) is an AKT inhibitor that binds to the Pleckstrin homology (PH) domain of AKT. AKT-IN-26 can be used in research related to AKT pathway-associated cell proliferation and cancer[1]. | [References]
[1] Lynn D et al, Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same, 2010-09-14. |
|
|